HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hypophosphatemia and hyperparathyroidism in a case of Bartter's syndrome.

Abstract
In an 18-year-old boy with Bartter's syndrome, hypophosphatemia was discovered (2.4 mg/100 ml) with normal serum calcium concentration (9.7 mg/100 ml) and elevated alkaline phosphatase level: 528 mU/ml (normal less than or equal to 150). Skeleton X-rays showed osteomalacia on the pelvic bones and metaphyseal rickets on the wrists. Plasma 25-hydroxycholecalciferol (25-OHCC) concentration was 7.2 ng/ml (normal = 13 +/- 4.4), and serum immunoreactive parathyroid hormone (iPTH) concentration 160 micron1Eq/ml (normal less than or equal to 150). Ca infusion (1500 mg/m2/12 h) induced an increase in serum P level to 3.2 mg/100 ml, in tubular phosphate reabsorption from 72 to 90%, while serum iPTH decreased to 33 micron1Eq/ml. Vitamin D2 administration (45 mg) resulted in increased 25-OHCC concentration to 28 ng/ml and in healing of pelvic osteomalacia. However, there was little change of the radiological aspect of the wrist and of serum phosphorus and iPTH concentrations. In a control 6-year-old hypokalemic girl, administration of parathyroid hormone (8 USP/kg) produced a marked phosphaturic response and an increase in urinary cyclic AMP excretion. These data suggest that hypophosphatemia can be attributed to secondary hyperparathyroidism in the patient with Bartter's syndrome. Hypokalemia does not impair the renal activity of parathyroid hormone.
AuthorsL Sann, L David, J Bernheim, R François
JournalHelvetica paediatrica acta (Helv Paediatr Acta) Vol. 33 Issue 3 Pg. 299-310 (Aug 1978) ISSN: 0018-022X [Print] Switzerland
PMID711493 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Vitamin D
  • Spironolactone
  • Sodium Chloride
  • Potassium Chloride
  • Renin
Topics
  • Adolescent
  • Alkalosis (etiology)
  • Bartter Syndrome (complications)
  • Humans
  • Hyperaldosteronism (complications)
  • Hyperparathyroidism (complications)
  • Hypokalemia (etiology)
  • Hypophosphatasia (complications)
  • Male
  • Potassium Chloride (therapeutic use)
  • Renin (blood)
  • Sodium Chloride (therapeutic use)
  • Spironolactone (therapeutic use)
  • Vitamin D (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: